评价发表的系统评价和荟萃分析的质量对首选报告项目的系统评价和荟萃分析 (PRISMA) 声明的认可。
Evaluation of the endorsement of the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement on the quality of published systematic review and meta-analyses.
机构信息
Section of Hygiene, Institute of Public Health, Università Cattolica del Sacro Cuore, Rome, Italy ; Faculty of Medicine, University of Belgrade, Belgrade, Serbia ; University Clinical-Hospital Center "Dr Dragisa Misovic-Dedinje", Belgrade, Serbia.
Section of Hygiene, Institute of Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.
出版信息
PLoS One. 2013 Dec 26;8(12):e83138. doi: 10.1371/journal.pone.0083138. eCollection 2013.
INTRODUCTION
PRISMA statement was published in 2009 in order to set standards in the reporting of systematic reviews and meta-analyses. Our aim was to evaluate the impact of PRISMA endorsement on the quality of reporting and methodological quality of systematic reviews and meta-analyses, published in journals in the field of gastroenterology and hepatology (GH).
METHODS
Quality of reporting and methodological quality were evaluated by assessing the adherence of papers to PRISMA checklist and AMSTAR quality scale. After identifying the GH journals which endorsed PRISMA in instructions for authors (IA), we appraised: 15 papers published in 2012 explicitly mentioning PRISMA in the full text (Group A); 15 papers from the same journals published in 2012 not explicitly mentioning PRISMA in the full text (Group B); 30 papers published the year preceding PRISMA endorsement from the same journals as above (Group C); 30 papers published in 2012 on the 10 highest impact factor journals in GH which not endorsed PRISMA (Group D).
RESULTS
PRISMA statement was referred in the IA in 9 out of 70 GH journals (12.9%). We found significant increase in overall adherence to PRISMA checklist (Group A, 90.1%; Group C, 83.1%; p = 0.003) and compliance to AMSTAR scale (Group A, 85.0%; Group C, 74.6%; p = 0.002), following the PRISMA endorsement from the nine GH journals. Explicit referencing of PRISMA in manuscript was not associated with increase in quality of reporting and methodological quality (Group A vs. B, p = 0.651, p = 0.900, respectively). Adherence to PRISMA checklist, and the compliance with AMSTAR were significantly higher in journals endorsing PRISMA compared to those not (Groups A+B vs. D; p = 0.003 and p = 0.016, respectively).
CONCLUSION
The endorsement of PRISMA resulted in increase of both quality of reporting and methodological quality. It is advised that an increasing number of medical journals include PRISMA in the instructions for authors.
简介
PRISMA 声明于 2009 年发布，旨在为系统评价和荟萃分析的报告制定标准。我们的目的是评估 PRISMA 认可对胃肠病学和肝脏病学（GH）领域期刊发表的系统评价和荟萃分析报告质量和方法学质量的影响。
方法
通过评估论文对 PRISMA 检查表和 AMSTAR 质量量表的依从性来评估报告质量和方法学质量。在确定了在作者指南（IA）中认可 PRISMA 的 GH 期刊后，我们评估了以下内容：15 篇 2012 年发表的明确在全文中提到 PRISMA 的论文（A 组）；15 篇来自同一期刊的 2012 年未在全文中明确提到 PRISMA 的论文（B 组）；来自上述相同期刊的 2011 年发表的 30 篇论文（C 组）；来自上述相同期刊的 2012 年发表的 30 篇未认可 PRISMA 的 GH 10 大影响因子期刊的论文（D 组）。
结果
在 70 种 GH 期刊中有 9 种（12.9%）在 IA 中提到了 PRISMA 声明。我们发现，总体上对 PRISMA 检查表的依从性显著增加（A 组为 90.1%，C 组为 83.1%，p = 0.003），对 AMSTAR 量表的依从性也显著增加（A 组为 85.0%，C 组为 74.6%，p = 0.002），这是在 9 种 GH 期刊认可 PRISMA 之后的情况。手稿中明确提到 PRISMA 与报告质量和方法学质量的提高无关（A 组与 B 组，p = 0.651，p = 0.900）。与不认可 PRISMA 的期刊相比，认可 PRISMA 的期刊对 PRISMA 检查表的依从性和 AMSTAR 的依从性更高（A+B 组与 D 组，p = 0.003 和 p = 0.016）。
结论
PRISMA 的认可提高了报告质量和方法学质量。建议越来越多的医学期刊将 PRISMA 纳入作者指南。
Zotero 插件